(Q39986102)

16 September 2017

title

Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways (English)

1 reference

16 September 2017

0 references

1 reference

Xudong Wu

1

1 reference

16 September 2017

Luyong Zhang

2

1 reference

16 September 2017

Emily Gurley

3

1 reference

16 September 2017

Elaine Studer

4

1 reference

16 September 2017

Jing Shang

5

1 reference

16 September 2017

Tao Wang

6

1 reference

16 September 2017

Cuifen Wang

7

1 reference

16 September 2017

Ming Yan

8

1 reference

16 September 2017

Zhenzhou Jiang

9

1 reference

16 September 2017

Phillip B Hylemon

10

1 reference

16 September 2017

Arun J Sanyal

11

1 reference

16 September 2017

William M Pandak

12

1 reference

16 September 2017

Huiping Zhou

13

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

47

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1905-1915

1 reference

Nonalcoholic fatty liver disease

16 September 2017

cites work

1 reference

7 January 2021

Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis

1 reference

7 January 2021

Review: The role of insulin resistance in nonalcoholic fatty liver disease

1 reference

7 January 2021

Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis

1 reference

7 January 2021

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

1 reference

7 January 2021

Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c

1 reference

7 January 2021

Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis.

1 reference

7 January 2021

Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent

1 reference

7 January 2021

Inhibitors of cathepsin B.

1 reference

7 January 2021

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis

1 reference

7 January 2021

Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury

1 reference

7 January 2021

Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications

1 reference

7 January 2021

1 reference

7 January 2021

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

1 reference

7 January 2021

The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats

1 reference

7 January 2021

HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes.

1 reference

7 January 2021

A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.

1 reference

7 January 2021

Lysosomal destabilization in p53-induced apoptosis

1 reference

7 January 2021

Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration

1 reference

7 January 2021

Protective Effect of N-Acetylcysteine in Tumor Necrosis Factor-α-Induced Apoptosis in U937 Cells: The Role of Mitochondria

1 reference

7 January 2021

Cellular localization and enzymatic activity of cathepsin B after spinal cord injury in the rat

1 reference

7 January 2021

Determination of intracellular reactive oxygen species and high mitochondrial membrane potential in Percoll-treated viable boar sperm using fluorescence-activated flow cytometry

1 reference

7 January 2021

A human hepatocellular in vitro model to investigate steatosis.

1 reference

7 January 2021

Animal models of steatosis

1 reference

7 January 2021

Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease

1 reference

7 January 2021

Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.

1 reference

7 January 2021

Licorice compounds glycyrrhizin and 18beta-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes

1 reference

7 January 2021

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

7 January 2021

Liquorice and its health implications

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22239

1 reference

16 September 2017

1 reference